What is Option Care Health Inc?
offers home and alternate site infusion services in the United States.
OPCH · Verdict
Solid reward · moderate risk
OPCH scores well on balance sheet and cash flow with no major weaknesses flagged in the model.
Based on 88% data coverage
OPCH · Verdict
Interest covered 3.3×
5% free-cash-flow margin
Model-based scoring. For information only — not financial advice.
offers home and alternate site infusion services in the United States. The company provides anti-infective therapy and services; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 5.45B, and a P/E ratio of 26.7x.
The scoring profile indicates moderate reward potential, with growth and valuation as the leading contributors. Risk indicators are moderate, consistent with typical market exposure.
For informational purposes only. Not financial advice.